These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Establishment of drug-resistant HIV-1 in latent reservoirs. Dahl V; Palmer S J Infect Dis; 2009 May; 199(9):1258-60. PubMed ID: 19338473 [No Abstract] [Full Text] [Related]
23. Health minister ignites row over drugs for HIV mothers. Check E Nature; 2004 Jul; 430(6998):389. PubMed ID: 15269730 [No Abstract] [Full Text] [Related]
24. Reducing mother-to-child transmission of HIV. Bolton KD; Hofmeyr GJ S Afr Med J; 2000 Apr; 90(4):322, 324. PubMed ID: 10957909 [No Abstract] [Full Text] [Related]
25. New drug regimen helps prevent HIV infection in infants. Health Care Financ Rev; 1999; 21(1):134-5. PubMed ID: 11481728 [No Abstract] [Full Text] [Related]
26. To test or not to test--ethical dilemmas and practical realities in the use of co-trimoxazole and nevirapine in HIV-infected adults. Hudson CP; Smith AN; Moodley J S Afr Med J; 2001 Aug; 91(8):656-8. PubMed ID: 11584779 [No Abstract] [Full Text] [Related]
27. South Africa: highest court orders government to provide antiretrovirals to prevent mother-to-child transmission. Gerntholtz L Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):50-2. PubMed ID: 14725243 [TBL] [Abstract][Full Text] [Related]
28. Preventing mother-to-child transmission of HIV—protecting this generation and the next. Lallemant M; Jourdain G N Engl J Med; 2010 Oct; 363(16):1570-2. PubMed ID: 20942674 [No Abstract] [Full Text] [Related]
29. Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis. Pilger D; Hauser A; Kuecherer C; Mugenyi K; Kabasinguzi R; Somogyi S; Harms G; Kunz A Antivir Ther; 2011; 16(1):109-13. PubMed ID: 21311114 [TBL] [Abstract][Full Text] [Related]
30. No turning back now. Bateman C S Afr Med J; 2000 Sep; 90(9):837-9. PubMed ID: 11081125 [No Abstract] [Full Text] [Related]
31. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. ; de Vincenzi I Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718 [TBL] [Abstract][Full Text] [Related]
32. [Encouraging study results. HIV from birth on--virostatic drugs can decrease the risk]. MMW Fortschr Med; 1999 Aug; 141(34):61. PubMed ID: 10726137 [No Abstract] [Full Text] [Related]
33. The controversies of nevirapine for preventing mother-to-child HIV transmission. Smith DM AIDS; 2006 Jan; 20(2):281-3. PubMed ID: 16511423 [No Abstract] [Full Text] [Related]
34. Nevirapine and perinatal transmission. AIDS Patient Care STDS; 2000 Apr; 14(4):226. PubMed ID: 10806648 [No Abstract] [Full Text] [Related]
36. [Nevirapine as an important component of therapy for HIV infection]. Kravchenko AV Vopr Virusol; 2009; 54(6):41. PubMed ID: 20030282 [No Abstract] [Full Text] [Related]
37. Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure. Mirochnick M; Siminski S; Fenton T; Lugo M; Sullivan JL Pediatr Infect Dis J; 2001 Aug; 20(8):803-5. PubMed ID: 11734746 [TBL] [Abstract][Full Text] [Related]
38. [HIV, breast feeding and antiretroviral agents]. Engebretsen IM; Tylleskär T Tidsskr Nor Laegeforen; 2010 Mar; 130(5):520-2. PubMed ID: 20224625 [No Abstract] [Full Text] [Related]
39. Prevention of vertical transmission of HIV-1 in resource-limited settings. Coutsoudis A; Kwaan L; Thomson M Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1163-75. PubMed ID: 20954881 [TBL] [Abstract][Full Text] [Related]
40. Nevirapine concentration in cervicovaginal and oropharyngeal secretions after single-dose administration to the mother. Harms G; Kunz A; Karcher H; Mugenyi K; Kurowski M Antivir Ther; 2005; 10(6):777. PubMed ID: 16218178 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]